{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:13:47Z","timestamp":1792034027270,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.pcad.2021.02.009","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T23:14:21Z","timestamp":1613862861000},"page":"2-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Asymptomatic peripheral artery disease: Silent but deadly"],"prefix":"10.1016","volume":"65","author":[{"given":"Adam A.","family":"Behroozian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.pcad.2021.02.009_bb0005","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui Michael","year":"2015","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.009_bb0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.amepre.2006.12.010","article-title":"Ethnic-specific prevalence of peripheral arterial disease in the United States","volume":"32","author":"Allison","year":"2007","journal-title":"Am J Prev Med"},{"issue":"13","key":"10.1016\/j.pcad.2021.02.009_bb0015","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.286.13.1599","article-title":"Leg symptoms in peripheral arterial disease associated clinical characteristics and functional impairment","volume":"286","author":"McGrae McDermott","year":"2001","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.pcad.2021.02.009_bb0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM190102211440804","article-title":"Dysbasia intermittens angiosclerotica (intermittent lameness of vascular origin)","volume":"144","author":"Putnam","year":"1901","journal-title":"Boston Med Surg J"},{"key":"10.1016\/j.pcad.2021.02.009_bb0025","series-title":"Dreschfeld Memorial Volume: Containing an Account of the Life, Work, and Writings of the Late Julius Dreschfeld, M. D., F. R. C. P., with a Series of Original Articles Dedicated to His Memory by Colleagues in the University of Manchester and Former Pupils","author":"Brockbank","year":"1908"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.009_bb0030","first-page":"645","article-title":"The diagnosis of ischaemic heart pain and intermittent claudication in field surveys","volume":"27","author":"Rose","year":"1962","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.009_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1358863X9600100112","article-title":"The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing","volume":"1","author":"Criqui","year":"1996","journal-title":"Vasc Med"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.009_bb0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/01.CIR.71.3.510","article-title":"The prevalence of peripheral arterial disease in a defined population","volume":"71","author":"Criqui","year":"1985","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.pcad.2021.02.009_bb0045","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","article-title":"Measurement and interpretation of the Ankle-Brachial Index","volume":"126","author":"Aboyans","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.009_bb0050","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jvs.2007.02.004","article-title":"A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences","volume":"45","author":"Sigvant","year":"2007","journal-title":"J Vasc Surg"},{"issue":"11","key":"10.1016\/j.pcad.2021.02.009_bb0055","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.009_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1358863X11431106","article-title":"Progression of asymptomatic peripheral artery disease over 1 year","volume":"17","author":"Mohler","year":"2012","journal-title":"Vasc Med"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.009_bb0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.009_bb0070","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ije\/25.6.1172","article-title":"Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population","volume":"25","author":"Leng","year":"1996","journal-title":"Int J Epidemiol"},{"issue":"8","key":"10.1016\/j.pcad.2021.02.009_bb0075","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.avsg.2010.06.001","article-title":"Asymptomatic peripheral arterial disease in Type 2 diabetes patients: a 10-year follow-up study of the utility of the ankle brachial index as a prognostic marker of cardiovascular disease","volume":"24","author":"Bund\u00f3","year":"2010","journal-title":"Ann Vasc Surg"},{"issue":"21","key":"10.1016\/j.pcad.2021.02.009_bb0080","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1161\/CIRCULATIONAHA.109.865600","article-title":"Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease","volume":"120","author":"Diehm","year":"2009","journal-title":"Circulation"},{"issue":"438","key":"10.1016\/j.pcad.2021.02.009_bb0085","first-page":"49","article-title":"The prognosis of non-critical limb ischaemia: a systematic review of population-based evidence","volume":"49","author":"Hooi","year":"1999","journal-title":"Br J Gen Pract"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.009_bb0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/000331979504600304","article-title":"Ankle\/arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality","volume":"46","author":"Kornitzer","year":"1995","journal-title":"Angiology"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.009_bb0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle Brachial Index combined with framingham risk score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.009_bb0100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jclinepi.2003.09.003","article-title":"Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study","volume":"57","author":"Hooi","year":"2004","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.009_bb0105","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/CIRCULATIONAHA.116.022971","article-title":"Parsing atherosclerosis","volume":"134","author":"Aronow Herbert","year":"2016","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.pcad.2021.02.009_bb0110","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1161\/CIRCULATIONAHA.107.736108","article-title":"Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication","volume":"117","author":"McDermott Mary","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.009_bb0115","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.CIR.79.3.549","article-title":"Neutrophil function in ischemic heart disease","volume":"79","author":"Mehta","year":"1989","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.009_bb0120","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1161\/01.CIR.87.6.1915","article-title":"Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study","volume":"87","author":"Lowe","year":"1993","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.009_bb0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/ejvs.2002.1599","article-title":"Exercise training reduces the acute inflammatory responseassociated with claudication","volume":"23","author":"Turton","year":"2002","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"18","key":"10.1016\/j.pcad.2021.02.009_bb0130","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1161\/CIRCULATIONAHA.109.918417","article-title":"Inflammation in peripheral artery disease","volume":"122","author":"Brevetti","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.009_bb0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1191\/1358863x03vm503oa","article-title":"Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease","volume":"8","author":"Silvestro","year":"2003","journal-title":"Vasc Med"},{"issue":"7","key":"10.1016\/j.pcad.2021.02.009_bb0140","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.104.513085","article-title":"C-reactive protein, Interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population","volume":"112","author":"Tzoulaki","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.009_bb0145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejvs.2004.11.001","article-title":"Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease","volume":"29","author":"Cassar","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.009_bb0150","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0950-821X(05)80707-8","article-title":"C-reactive protein and \u03b1-1-acid glycoprotein in monitoring of patients with chronic arterial occlusion of the lower limbs","volume":"7","author":"Majewski","year":"1993","journal-title":"Eur J Vasc Surg"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.009_bb0165","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with Evolocumab and outcomes in patients with peripheral artery disease","volume":"137","author":"Bonaca Marc","year":"2018","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.pcad.2021.02.009_bb0170","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.pcad.2021.02.009_bb0175","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.119.039609","article-title":"Rivaroxaban with or without aspirin in patients with heart failure and chronic coronary or peripheral artery disease","volume":"140","author":"Branch Kelley","year":"2019","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.pcad.2021.02.009_bb0180","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.pcad.2021.02.009_bb0185","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","article-title":"Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials","volume":"301","author":"Berger","year":"2009","journal-title":"JAMA"},{"issue":"7329","key":"10.1016\/j.pcad.2021.02.009_bb0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists","year":"2002","journal-title":"BMJ (Clinical Research ed)"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.009_bb0195","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2796.2006.01763.x","article-title":"Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial","volume":"261","author":"Critical Leg Ischaemia Prevention Study","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.pcad.2021.02.009_bb0200","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"Belch","year":"2008","journal-title":"BMJ (Clinical Research ed)"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.009_bb0205","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrcardio.2010.65","article-title":"Aspirin for asymptomatic atherosclerosis?","volume":"7","author":"Patrono","year":"2010","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2021.02.009_bb0210","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.2010.221","article-title":"Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial","volume":"303","author":"Fowkes","year":"2010","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.pcad.2021.02.009_bb0215","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman Marie","year":"2017","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.pcad.2021.02.009_bb0220","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jacc.2016.02.014","article-title":"Effect of statin treatment on modifying plaque composition","volume":"67","author":"Park","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2021.02.009_bb0225","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary AtherosclerosisA randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.009_bb0230","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jacc.2015.11.052","article-title":"Statins for prevention of cardiovascular events in a low-risk population with low Ankle Brachial Index","volume":"67","author":"Ramos","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"41","key":"10.1016\/j.pcad.2021.02.009_bb0235","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","volume":"35","author":"Kumbhani","year":"2014","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.pcad.2021.02.009_bb0240","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.117.032361","article-title":"Association of statin dose with amputation and survival in patients with peripheral artery disease","volume":"137","author":"Arya","year":"2018","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.pcad.2021.02.009_bb0245","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.0000090686.57897.F5","article-title":"Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease","volume":"108","author":"Mohler Emile","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.009_bb0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ehj.2003.10.033","article-title":"Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease","volume":"25","author":"\u00d6stergren","year":"2004","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.009_bb0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting\u2013enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.009_bb0260","doi-asserted-by":"crossref","DOI":"10.1249\/MSS.0000000000002109","article-title":"Effects of lifestyle physical activity on vascular function in asymptomatic peripheral arterial disease","volume":"52","author":"Laslovich","year":"2020","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.009_bb0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1249\/MSS.0000000000002109","article-title":"Effects of lifestyle physical activity on vascular function in asymptomatic peripheral arterial disease","volume":"52","author":"Laslovich","year":"2020","journal-title":"Med Sci Sports Exerc"},{"issue":"25","key":"10.1016\/j.pcad.2021.02.009_bb0270","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.009_bb0275","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jn\/134.3.562","article-title":"Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans","volume":"134","author":"Svilaas","year":"2004","journal-title":"J Nutr"},{"issue":"8","key":"10.1016\/j.pcad.2021.02.009_bb0280","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.numecd.2005.08.006","article-title":"Dietary patterns: a mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk","volume":"16","author":"Panagiotakos","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.pcad.2021.02.009_bb0285","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.numecd.2017.09.011","article-title":"Relationship between Mediterranean diet and asymptomatic peripheral arterial disease in a population of pre-menopausal women","volume":"27","author":"Mattioli","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.009_bb0290","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/oxfordjournals.aje.a116294","article-title":"Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh artery Study","volume":"135","author":"Gerald","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.009_bb0295","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.CIR.94.1.19","article-title":"Modulation of oxidant stress in vivo in chronic cigarette smokers","volume":"94","author":"Reilly","year":"1996","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.pcad.2021.02.009_bb0300","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1365-2362.1993.tb00724.x","article-title":"Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution","volume":"23","author":"Freeman","year":"1993","journal-title":"Eur J Clin Investig"},{"issue":"5 Pt 1","key":"10.1016\/j.pcad.2021.02.009_bb0305","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.88.5.2149","article-title":"Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults","volume":"88","author":"Celermajer","year":"1993","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.009_bb0310","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1358863X17749300","article-title":"The goal line is in sight","volume":"23","author":"Beckman","year":"2018","journal-title":"Vasc Med"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.009_bb0315","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1358863X17745371","article-title":"Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test","volume":"23","author":"Itoga","year":"2018","journal-title":"Vasc Med"},{"issue":"10109","key":"10.1016\/j.pcad.2021.02.009_bb0320","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/S0140-6736(17)32250-X","article-title":"Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial","volume":"390","author":"Lindholt","year":"2017","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.pcad.2021.02.009_bb0325","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.120.045627","article-title":"The big MAC attack on peripheral artery disease","volume":"141","author":"Pradhan Aruna","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.009_bb0330","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.2018.8357","article-title":"For peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index: US preventive services task Force recommendation statement","volume":"320","author":"Force","year":"2018","journal-title":"JAMA"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062021000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062021000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:17:41Z","timestamp":1758500261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062021000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":64,"alternative-id":["S0033062021000232"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2021.02.009","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymptomatic peripheral artery disease: Silent but deadly","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2021.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}